Bunge misses Q2 earnings estimates but raises full-year outlook

Earnings
โดย Zacks Investment Research·Read original
Summary · why it matters

Bunge Global reported second-quarter 2026 adjusted earnings of $2.00 per share, missing the Zacks Consensus Estimate of $2.03 by 1.5% despite a 52.7% year-over-year increase. Net sales surged 88.3% to $24.04 billion, beating the consensus mark of $23.49 billion, driven by higher volumes across all segments. The company raised its full-year 2026 adjusted earnings guidance to a range of $9.25 to $9.75 per share, up from the prior $9.00 to $9.50, citing stronger expected results in soybean and softseed processing. Adjusted total EBIT more than doubled to $665 million, with gross profit climbing to $1.68 billion from $738 million a year earlier. Bunge also noted that cash used for operating activities improved to an outflow of $1.13 billion in the first six months of 2026, compared with an outflow of $1.36 billion in the same period last year.

Impact on stocks 4

Synthetic Biology (non-pharma) · 3 stocks
Bunge Global SA
BG
▲ PositiveCapitalrelevance

Bunge raised full-year adjusted earnings guidance despite missing Q2 estimates by a small margin.

Materials · 1 stocks